Patient | Gender | Age | SUN | Cause | Treatment |
---|---|---|---|---|---|
1 | Male | 34 | Anterior | HLA-B27 | Periocular Triamcinolone |
2 | Male | 40 | Anterior | HLA-B27 | Intravitreal dexamethasone |
3 | Male | 48 | Anterior | HLA-B27 | Oral steroids |
4 | Male | 37 | Anterior | Idiopathic | Oral steroids |
5 | Female | 23 | Anterior | Idiopathic | Oral steroids |
6 | Female | 28 | Intermediate | Idiopathic | Periocular Triamcinolone |
7 | Female | 25 | Intermediate | Idiopathic | Periocular Triamcinolone |
8 | Female | 53 | Intermediate | Idiopathic | Periocular Triamcinolone |
9 | Female | 50 | Intermediate | Idiopathic | Intravitreal dexamethasone |
10 | Female | 35 | Intermediate | Idiopathic | Intravitreal dexamethasone |
11 | Female | 63 | Posterior | Sarcoidosis | Oral steroids + Methotrexate |
12 | Female | 54 | Posterior | Sarcoidosis | Oral steroids + Methotrexate |
13 | Female | 57 | Posterior | Sarcoidosis | Oral steroids + Adalimumab |
14 | Female | 61 | Posterior | Sarcoidosis | Oral steroids + Adalimumab |
15 | Male | 61 | Posterior | Birdshot | Oral steroids + Tocilizumab |
16 | Male | 34 | Posterior | Birdshot | Oral steroids + Cyclosporine |
17 | Female | 59 | Posterior | Idiopathic | Oral steroids |
18 | Female | 50 | Posterior | Idiopathic | Oral steroids |
19 | Female | 67 | Panuveitis | Sarcoidosis | Oral steroids + Adalimumab |
20 | Female | 21 | Panuveitis | Sarcoidosis | Oral steroids + Adalimumab |
21 | Female | 35 | Panuveitis | Chronic VKH | Oral steroids + Azathioprine |
22 | Female | 47 | Panuveitis | Chronic VKH | Periocular triamcinolone+Azathioprine |
23 | Female | 61 | Panuveitis | Idiopathic | Oral steroids |
24 | Male | 53 | Panuveitis | Idiopathic | Oral steroids |